Egetis Therapeutics AB (publ)

LSE:0ABW Stock Report

Market Cap: SEK 1.2b

Egetis Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0ABW Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Jan 25SellSEK 1,431,249Yilmaz MahshidIndividual213,089SEK 6.82
08 Nov 24BuySEK 25,020Christian SonessonIndividual6,000SEK 4.22
08 Nov 24BuySEK 280,150Henrik KrookIndividual65,000SEK 4.31
07 Oct 24BuySEK 42,250Yilmaz MahshidIndividual10,000SEK 4.23
07 Oct 24BuySEK 43,103Nicklas WesterholmIndividual10,142SEK 4.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0ABW?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders53,923,37415%
VC/PE Firms61,233,27917%
Private Companies61,976,21117.3%
Institutions87,683,41324.4%
General Public94,421,84926.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.8%.

Top Shareholders

Top 25 shareholders own 73.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.1%
Frazier Life Sciences Management, LP
61,233,279SEK 199.3m0%0.94%
10%
Peter Lindell
36,084,817SEK 117.5m0%no data
9.4%
Cetoros AB
33,776,221SEK 109.9m0%no data
7.5%
Fourth Swedish National Pension Fund (AP4)
26,942,859SEK 87.7m0%0.04%
4.92%
Avla Holding AB
17,668,330SEK 57.5m0%no data
3.85%
Flerie AB (publ)
13,844,458SEK 45.1m0%7.54%
3.84%
Unionen, Endowment Arm
13,800,000SEK 44.9m0%1.63%
3.76%
Thomas Eldered
13,499,458SEK 43.9m0%no data
3.62%
Handelsbanken Asset Management
13,021,165SEK 42.4m0%0.01%
2.93%
Recipharm AB (publ)
10,531,660SEK 34.3m0%no data
2.24%
Avanza Fonder AB
8,044,640SEK 26.2m0%0.02%
2.1%
Linc AB
7,532,021SEK 24.5m0%1.32%
0.87%
Mats Blom
3,134,762SEK 10.2m0%no data
0.47%
SEB Investment Management AB
1,682,563SEK 5.5m0%no data
0.29%
FCG Fonder AB
1,025,189SEK 3.3m0%0.03%
0.28%
Swedbank Robur Fonder AB
1,000,000SEK 3.3m0%no data
0.11%
Henrik Krook
404,593SEK 1.3m0%no data
0.086%
Financiere Arbevel
310,000SEK 1.0m0%0.02%
0.079%
Thomas Lonngren
283,158SEK 921.7k0%no data
0.068%
Nicklas Westerholm
242,718SEK 790.0k0%no data
0.056%
Consensus Asset Management, Asset Management Arm
200,000SEK 651.0k0%0.08%
0.049%
Skandia Fonder AB
176,659SEK 575.1k0%no data
0.028%
Yilmaz Mahshid
100,000SEK 325.5k-68.1%no data
0.021%
Storebrand Fonder AB,
73,895SEK 240.5k0%no data
0.012%
Christian Sonesson
42,298SEK 137.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 16:20
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Egetis Therapeutics AB (publ) is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Patrick LangstromABG Sundal Collier Sponsored
Oscar Haffen LammBryan Garnier & Co